Allarity Therapeutics, Inc.
ALLR
$1.07
-$0.06-5.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.45M | -11.59M | -1.63M | -3.84M | -1.72M |
| Total Depreciation and Amortization | 1.00K | 5.00K | 1.00K | 2.00K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 340.00K | 9.30M | -2.01M | -534.00K | -3.44M |
| Change in Net Operating Assets | 3.91M | -3.16M | -3.58M | 2.89M | 3.48M |
| Cash from Operations | -3.21M | -5.44M | -7.22M | -1.49M | -1.67M |
| Capital Expenditure | -298.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -298.00K | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 1.34M | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -1.34M | -- | -1.00K |
| Issuance of Common Stock | 4.24M | 5.43M | 27.65M | 40.00K | 523.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 2.94M | -- | -- | 0.00 |
| Repurchase of Preferred Stock | 0.00 | -3.50M | -- | -- | 0.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.24M | 4.87M | 26.31M | 1.38M | 522.00K |
| Foreign Exchange rate Adjustments | 339.00K | -195.00K | -172.00K | 253.00K | -83.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.07M | -770.00K | 18.92M | 146.00K | -1.23M |